Evidence map›Paper›PMID 39980659›Full record

ArticleToxicology reports2025

Corrigendum to "Mitigation of cisplatin-induced cardiotoxicity by Isorhamnetin: Mechanistic insights into oxidative stress, inflammation, and apoptosis modulation" [Toxicol. Rep. 12 (2024) 564-573].

Rawan Abudalo, Omar Gammoh, Sara Altaber, Yousra Bseiso, Esam Qnais, Mohammed Wedyan, Muna Oqal, Abdelrahim Alqudah

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Rawan AbudaloDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
Omar GammohDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.
Sara AltaberDepartment of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
Yousra BseisoDepartment of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
Esam QnaisDepartment of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
Mohammed WedyanDepartment of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
Muna OqalDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
Abdelrahim AlqudahDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.toxrep.2024.05.003.].

Identifiers

PMID39980659
PMCPMC11841216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.